BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28560675)

  • 21. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
    Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
    Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
    Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
    Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.
    Hong Y; Zhang Q
    Tumour Biol; 2016 May; 37(5):5663-74. PubMed ID: 26758432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells.
    Eslami-S Z; Cortés-Hernández LE; Alix-Panabières C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32764280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cells in early breast cancer: A connection with vascular invasion.
    Maltoni R; Fici P; Amadori D; Gallerani G; Cocchi C; Zoli M; Rocca A; Cecconetto L; Folli S; Scarpi E; Serra P; Fabbri F
    Cancer Lett; 2015 Oct; 367(1):43-8. PubMed ID: 26184997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Modified Method to Isolate Circulating Tumor Cells and Identify by a Panel of Gene Mutations in Lung Cancer.
    Wang H; Wu J; Zhang Q; Hao J; Wang Y; Li Z; Niu H; Zhang H; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821995275. PubMed ID: 34032165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.
    Bozzetti C; Quaini F; Squadrilli A; Tiseo M; Frati C; Lagrasta C; Azzoni C; Bottarelli L; Galetti M; Alama A; Belletti S; Gatti R; Passaro A; Gradilone A; Cavazzoni A; Alfieri R; Petronini PG; Bonelli M; Falco A; Carubbi C; Pedrazzi G; Nizzoli R; Naldi N; Pinto C; Ardizzoni A
    PLoS One; 2015; 10(11):e0142891. PubMed ID: 26571236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration.
    Pugia M; Magbanua MJM; Park JW
    Adv Exp Med Biol; 2017; 994():119-131. PubMed ID: 28560671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients.
    Perelmuter VM; Grigoryeva ES; Savelieva OE; Alifanov VV; Andruhova ES; Zavyalova MV; Bragina OD; Garbukov EY; Menyailo ME; Khozyainova AA; Denisov EV; Cherdyntseva NV; Tashireva LA
    Sci Rep; 2024 May; 14(1):12245. PubMed ID: 38806508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.
    Wu F; Zhu J; Mao Y; Li X; Hu B; Zhang D
    Dis Markers; 2017; 2017():9474532. PubMed ID: 29430076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
    Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
    J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.
    Bulfoni M; Gerratana L; Del Ben F; Marzinotto S; Sorrentino M; Turetta M; Scoles G; Toffoletto B; Isola M; Beltrami CA; Di Loreto C; Beltrami AP; Puglisi F; Cesselli D
    Breast Cancer Res; 2016 Mar; 18(1):30. PubMed ID: 26961140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Optically Induced Dielectrophoresis (ODEP)-Based Microfluidic System for the Isolation of High-Purity CD45
    Liao CJ; Hsieh CH; Chiu TK; Zhu YX; Wang HM; Hung FC; Chou WP; Wu MH
    Micromachines (Basel); 2018 Oct; 9(11):. PubMed ID: 30715062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
    Alvarez Cubero MJ; Lorente JA; Robles-Fernandez I; Rodriguez-Martinez A; Puche JL; Serrano MJ
    Methods Mol Biol; 2017; 1634():283-303. PubMed ID: 28819860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.